Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients

RecruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions

Hyperphosphatemia

Interventions

DRUG

the standard-dose group (4 g/day)

Patients with chronic kidney disease undergoing hemodialysis and controlling hyperphosphatemia

Trial Locations (1)

RECRUITING

Jesus Hospital, Jeonju

All Listed Sponsors

lead

Kyowa Kirin Korea Co., Ltd.

INDUSTRY